As of April 16, 2025, Gubra A/S (GUBRA.CO) has a market cap of $0.90 billion USD. According to our data, Gubra A/S is ranked No.5176 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.90 B |
-41.51%
|
Dec 30, 2024 | $1.54 B |
399.20%
|
Dec 29, 2023 | $0.31 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
![]() Denmark
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
Market Cap | = | GUBRA.CO Stock Price | * | GUBRA.CO Shares Outstanding |
= | $55.24 | * | 16.31 M | |
= | $0.90 B |